Corticotropin-releasing factor (CRF) has potent behavioral effects when administered intracerebroventricularly to rats. CK7 and its receptors are found in an uneven distribution in the brain. In an effort to localize the site of the anorectie effect of CRF, enogenous CRF or saline was injected into cannulas directed toward the paraventricular hypo~halamic nucleus (PVN), lateral hypothalamus, ventromedial hypothalamus, globus pallidus, or striatum of rats. CRF decreased food intake only when injected into the PVN. In subsequent experiments PVN injections of CRF were shown to (1) increase grooming and movement; (2) not induce a conditioned taste aversion to saccharin in a single bottle test; and (3) inhibit the increase in feeding induced by injections of norepinephrine into the PVN. These results suggest that CRF induces not only anorexia, but also increased movement and grooming by action in the PVN.
INTRODUCTION
A 41 amino acid peptide which fulfills the criteria for physiological corticotropin-releasing factor (CRF) was characterized in 1981 by Spiess et al. 19 . This discovery allowed two lines of research to proceeed. First, the behavioral effects of CRF administered into the lateral ventricles of rats could be studied. Rats given CRF intracerebroventricularly (i.c.v.) have been reported to groom more 4't4, move and rear less in the open field 2°, and to move more in a familiar environment 4'14'2°. These behaviors have been reported as being similar to those behaviors seen in rats exposed to stressors.
The second line of research made possible by the discovery of CRF was the use of immunohistochemical and radioimmunoassay techniques in localizing CRF in the brain 6'1°'13.16"17"21. CRF, while high in concentration in the median eminence as would be expected for a releasing factor, is also found in an uneven distribution throughout many intra-and extrahypothalamic nuclei. Thus, CRF, given via the relatively non-specific technique of intraventricular injection, changes consummatory behaviors including feeding and grooming in the rat. In the experiments reported here, we examined the effects on eating and other behaviors of CRF administered via the more specific method of local, intracerebral injection.
Our initial study focused on food intake alone. We selected 5 areas for testing with local injections of CRF. These areas have been shown by lesioning and/or electrical stimulation techniques to be important in food intake. They include the paraventricular nucleus of the hypothalamus (PVN), the lateral hypothalamus (LH), the ventromedial nucleus of the hypothalamus (VMH), the globus pallidus (GP) and the striatum (S) 15. When this initial study showed that CRF significantly suppressed f,~od intake when administered into the PVN but not when injected in the other nuclei, we performed 3 more experiments aimed at better characterizing the effects of CRF in the PVN. The first of these experiments was de. signed to determine the behavioral specificity of CRF administered into the PVN. As norepinephrine has been well characterized to increase feeding following local injection into the PVN il, we next determined the effects of CRF administered in the PVN on fee~l-ing induced by norepinephrine (NE) administered in the PVN. CRF has been shown to produce a conditioned taste aversion when administered into the lateral ventricle s . We therefore also examined whether CRF would produce a taste aversion after injection into the PVN.
MATERIALS AND METHODS
In the first experiment, 33 male Sprague-Dawley rats (250-300 g) were housed individually in a 12 h light/12 h dark, temperature-controlled environment. Stainless-steel cannulas (23 gauge) were stereotaxically implanted into the following brain areas: PVN, VMH, LH, GP and S. Coordinates used for implantation are shown in Table I .
At least 5 days were allowed for recovery. Then, after 24 h of food deprivation, rats were administered ovine CRF (0.5 gg; Peninsula) or normal saline in a 0.5 gl volume via the indwelling cannulas. Four days later, after a similar de, privation, rats received the treatment not received on the first day. Drug treatments were counterbalanced to control for trial effects.
Injections were made with a 30-gauge canntlla which extended 0.5 mm below the end of the guide cannula. The injection was given over a 30-s period using a hand-held microsyringe and the injection cannula was left in place an additional 10 s. Immediately after injection, each rat was returned to its home cage along with two preweighed pellets of Purina rat chow. Intake was calculated by weighing I and 2 h after injection. After testing was completed, animals were sacrificed by intracardiac perfusion with formalin. Brains were fixed with formalin-10% sucrose solution and stained with Cresyl violet. Cannula placement was verified by comparison with the atlas of the rat brain by Pellegrino et al. ~8. Data from rats with incorrectly placed cannulas were discarded. Data were analyzed by ANOVA, followed by repeated measures t-tests to compare intakes after saline vs CRF at each site at I and 2 h.
In the second experiment, 12 male Sprague-Dawley rats were implanted with cannulas in the PVN at in the first experiment. Following a 5-day recovery period, the animals were injected with 0.5/zg of CRF or saline as in the first experiment. Testing was done in home cages at 16.00 h with rats in the two following conditions: 24 h food deprivation, and no food deprivation. In a counterbalanced design, each animal received saline and CRF treatments in both conditions; thus receiving 4 trials spaced by at least 3 days. After injection, each animal was observed in its home cage by an experienced rater blind to the drug treatment, as described previously 14. Each animal was observed once per minute. Observed behaviors were classified into one of 6 mutually exclusive categories: grooming, moving, resting, eating, drinking, or rearing. Food intake was measured as in the first experiment. The behavioral data were analyzed with a 2-factor ANOVA (CRF treatment x previous deprivation). Food intake data in the deprived condition were analyzed svith t-tests for repeated measures. Intake in the non-deprived condition was minimal and therefore was not analyzed. In a third experiment, 12 male Sprague-Dawley rats with PVN cannulas were treated as in the first two experiments with the exception that they were not food-deprived prior to testing. Animals received injections of CRF (0.5 mg in a 0.25-,ul volume) or normal saline (NS) followed immediately by injections of 50 nmol/0.25 pl of NE (Sigma, St. Louis, MO) or acidified normal saline (NSA, pH 3). Each rat was tested 3 times, with all animals receiving the following treatments: NS/NSA, NS/NE, and CRF/ NE. Some of these animals were also tested with a lower dose of NE (with NS and CRF); these data are not presented here. Rats that failed to eat 0.5 g of food in the first hour after the NS/NE treatment were excluded from further analysis. Data were analyzed initially with a one-way ANOVA; the least significant difference procedure was then used to evaluate pairwise comparisons.
A fourth experiment used 12 male Sprague-Dawley rats, each with a cannula in the PVN. For 4 days following surgery, rats were given ad libitum food and water. Following this recovery period, rats were trained to drink water in a defined period by restricting access to water to only 12.00-13.00 h each day for one week. The next day, rats were given a preweighed amount of 0.15% sodium saccharin solution in their usual water bottles from 12.00-13.00 h. Immediately after 30 min of exposure to saccharin, a 0.5-/d injection into the PVN of CRF (0.5 itg; a dose that suppressed food intake in the previous experiments) or NS was administered. Amount consumed was determined by weight. After a l-day return to the 1 h/day access to water regimen, the animals were re-exposed to saccharin in the same manner as previously described for 30 min, This methodology is essentially the same as had been used in our laboratory previously to demonstrate conditioned taste aversion to saccharin after i c.v. administration of CRF s. Saccharin solution intakes on the second day were compared with t-tests for independent groups. . Rats were food-deprived for 24 h prior to testing, and each rat was tested with both saline and CRF. Numbers at bottom indicate group sizes; * indicates a significant difference from the corresponding saline condition (P < 0.05).
(0.5/~g) had a significant effect on food intake was the PVN. At 1 h, the CRF-treated rats with cannulas in the PVN showed a significant suppression of mean food intake of 62.9% (t(8) = 4.215, P < 0.05). At 2 h, mean intake in these rats was reduced by 32.9% (t(8) = 3.63, P < 0.05). The second experiment was designed to demonstrate the effects of CRF administered into the PVN on behaviors besides feeding in different states of starvation. As shown in Fig. 2 , CRF (0.5/zg) administered into the PVN in the food-deprived condition decreased food intake significantly at 2 h (t(ll) = 4.0, P < 0.05). At 1 h, this decreased approached significance (t(ll) = 2.17, P = 0.053, repeated measures t-test, two-tailed). Fig. 3 shows the frequency of behaviors observed in 4 conditions: no deprivation, normal saline; no deprivation, CRF (0.5/,tg in PVN); 24 h food deprivation, normal saline; and 24 h food deprivation, CRF (0.5/~g in PVN). Two-way analysis of variance indicated a significant effect of CRF on grooming as well as a significant interaction of deprivation with CRF treatment (FHt = 24.67 and 5.45, respectively, P < 0.05). As expected, both CRF treatment and deprivation state significantly affected frequency of eating behaviors (Ft.ll = 9.19 and 23.54, respectively, P < 0.05). The deprivation x CRF interaction was also significant (Ft.tl = 9.67, P < 0.05). The frequency of observed drinking behavior was affected in a manner similar to that of feeding behavior, with significant effects of CRF and deprivation state and a significant interaction.
The frequencies of behaviors classified as movement and resting were generally affected in a reciprocal manner by both CRF and deprivation state. For resting behavior, there were significant effects of treated rats vs saline-treated rats on the re-exposure day showed t = 0.39, n.s. Fig. 5 shows the cannula tract caused by a guide cannula directed toward the PVN. The injectien cannula extended 0.5 mm beyond the end of the guide cannula. CRF and deprivation state and a significant interaction (Fi.~l = 24.17, 25.56 and 9.16, respectively, all P's < 0.05). Observed frequency of rearing was not significantly affected by CRF or deprivation state.
The third experiment showed that CRF administered into the PVN suppressed food intake stimulated by NE (Fig. 4) . ANOVA for the first and second hour data showed F2.11 = 20.47 and 25.09, respectively (P < 0.0001). Second hour means of cumulative food intakes were as follows: NS/NSA = 1.32 + 0.5 g; NS/NE = 4.7 + 0.6 g; and CRF/NE = 2.5 + 0.5 g. PVN injections of NE significantly increased cumulative food intake at 1 and 2 h (P < 0.05), and animals ate significantly less in the CRF/NE condition than in the NS/NE condition at both time points (P < 0.05). Results of the single bottle taste aversion test showed that the 7 animals given CRF injections drank 16.2 + 1.5 ml of saccharin solution on day I and 20.6 + 1.5 ml on re-exposure. The 5 rats given saline injections on day 1 drank 14.4 + 1.7 mi and 15.5 + 4.4 ml on re-exposure. Thus, both sets of rats showed an increase on re-exposure. A t-test (independent groups) comparing intake of the CRF-CRF has been shown to have potent behavioral effects (including decreasing food intake and increasing grooming) when administered i.c.v. 4"14"2°. These effects are independent of its role in the hypothalamic-pituitary-adrenai axis ~4. It also has been shown to have a wide intra-and extrahypothalamic distributionl7o Because of these findings, we measured the amount of food eaten by food-deprived rats after receiving either CRF or saline in a local, intracerebral injection into one of 5 brain sites including the PVN, LH, VMH, GP or S. CRF caused a significant reduction of food intake when administered into the PVN but not when administered into the other 4 sites. Reasons for this specificity of effect of exogenous CRF are not immediately apparent from reports on the distributions of CRF and CRF receptors. Thus, while CRF concentration and CRF binding is high in the PVN, CRF and CRF receptors are by no means found exclusively in the PVN and these distributions cannot explain the specificity we found in behavioral response. Therefore, specific connections of the PVN may provide clues to the specificity of the behavioral response. While the PVN is intimately connected with the median eminence, it is unlikely that this is the specific outflow tract of importance since i.c.v, administration of CRF causes its anorectic and grooming effects in hypophysectomized animals ~4. However, the anorectic effects of i.c.v. CRF are attenuated in rats with demedullated adrenal glands 7, which suggests the important participation of autonomic nervous system arousal in this behavioral effect. The present results suggest that the PVN may be the site of maximal anorectic response to CRF because of its powerful effects on autonomic function. Future studies on the effects of CRF administered in the PVN in animals with various lesions affecting autonomic nervous system function may be helpful in clarifying this issue.
The second set of experiments demonstrated that PVN injections of exogenous CRF cause the entire behavioral syndrome (i.e. decreased eating, increased grooming, increased movement) that is induced by exogenous CRF administered i.c.v., where it is presumably more diffusely distributed. Whether injection of CRF into other brain nuclei could elicit only part of this behavioral syndrome (e.g. increased grooming without decreased feeding) remains to be tested. Interestingly, the increases noted in grooming and movement after CRF was injected into the PVN were not significantly affected by the length of preceding food deprivation. These results suggest that the CRF-induced grooming is not simply part of the natural satiety sequence described by Antin et al. ~. If it were part of a satiety sequence one would expect changes in level of hunger (i.e. length of prior food deprivation) to afi'ect the magnitude of the CRF-induced grooming response 3. This did not occur.
NE stimulates feeding in sated rats when delivered into the PVN, and lesions of the PVN inhibit NE-induced feeding tl. As we showed in the first experiment, CRF inhibits feeding induced by starvation when delivered into the PVN. CRF (i.c.v.) has been shown to inhibit the feeding induced by NE (i.c.v.) ~2.
We extended this finding further to show that this interaction is the same at the local level. This type of interaction of two exogenously administered substances is of uncertain physiological relevance. However, the recent findings that NE-induced feeding and PVN-a2-receptor numbers are significantly affected by corticosterone levels in the rat suggest that the CRF and NE systems may have important physiological interactions 2.9.
The failure of PVN injections of CRF to induce a conditioned taste aversion in a single bottle test stands in contrast to the previously reported findings of a taste aversion induced by CRF i.c.v, s. However, the significance of this difference in results is unclear without further testing with a wider dose range.
In summary, CRF decreased food intake when administered into the PVN but not into a numoer of other CNS areas known to be involved in food intake. This finding, along with earlier studies, suggests that the anorectic effects of CRF in the PVN may be related to its effects in autonomic arousal controlled by the PVN. PVN injections of CRF induced not only the anorectic effects but also the increased grooming and movement previously reported for rats after i.c.v, injection of CRF.
